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1. INTRODUCTION 
 Medicinal Chemistry has its roots in several branches of chemistry and 
biology. It is concerned with the study, identification and synthesis of the metabolic 
products of drugs and related compounds.  It also attempts to establish relationship 
between structure and function and to link biodynamic behavior with chemical 
reactivity and physical properties. However, essentially it concerns with the 
understanding of mechanisms of action of drugs. Besides this, medicinal chemistry 
also involves the isolation, characterization and synthesis of compounds that can be 
used in medicine for the prevention, treatment and cure of diseases. Thus, it provides 
chemical basis for the interdisciplinary field of therapeutics. 
The primary objective of medicinal chemistry is the design and discovery of 
new compounds that are suitable for use as drugs. The discovery of a new drug 
requires not only its design and synthesis but also the development of testing methods 
and procedures, which are needed to establish how a substance operates in the body 
and its suitability for use as a drug. Drug discovery may also require fundamental 
research into the biological and chemical nature of the diseased state. This and other 
aspects of drug design and discovery require input from specialists in other fields, 
such as biology, biochemistry, pharmacology, mathematics, computing and medicine 
amongst others, and the medicinal chemist to have outline knowledge of these fields. 
          2-Azetidinone and 4-thiazolidinone have played an important role in medicinal 
chemistry. Moreover they have been studied extensively because of  their  ready  
accessibility,  diverse  chemical  reactivity  and  broad  spectrum  of biological 
activity. 
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1.1.   2-AZETIDINONE 
  2-Azetidinone, commonly known as β-lactams, is a four member cyclic amide 
which was first synthesized by Staudinger in 1907. They are the carbonyl derivatives 
of azetidines containing carbonyl group at the 2nd position. 
Structure: 
                                                             
NH
O                                     
Molecular formula   : C3H5NO 
Molecular weight     : 71.08 
Synonym                  : 2-Azacyclobutanone, Propiolactams 
Physical properties: 
Description              : Colourless solid 
Melting point           : 73-74º C 
Boiling point            : 106º C 
Density                     : 1.119 g/cm3 
Molar refractivity     : 17.314 cm3 
Solubility                  : Soluble in ethanol, acetone; slightly soluble in benzene 
Stability                    : Stable under normal temperature and condition 
  The 2-azetidinone (β- lactams) ring is a common structural feature of a 
number of broad spectrum β-lactam antibiotics including penicillins, cephalosporins, 
carbapenems, nocardicin and monobactams which have been widely used as 
chemotherapeutic agents to treat bacterial infection and microbial diseases. Apart 
from antibiotic activity β- lactam also possess cholesterol inhibition, antithrombotic, 
antiviral and antitumor activities. (Mrunmayee Toraskar. et al., 2010) 
 It has been reported that introduction of different substituents to four 
membered β-lactam nucleus tend to exert profound influence in conferring promising 
3 
  
biological activities. A large number of 3-chloro monocyclic β-lactam possesses 
powerful antibacterial, antimicrobial, anti-inflammatory, anticonvulsant & 
antitubercular activities. They also function as enzyme inhibitors & are effective on 
the central nervous system (Ameya A.Chavan. et al., 2007). Subsequently 2-
azetidinones were highlighted as a potent mechanism based inhibitor of several 
enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human 
cytomegalovirus protease and serine protease enzyme. These derivatives are also 
known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, 
antiparkinsonism, antidiabetic and vasopressin antagonist activity. (Mehta PD. et al., 
2010) 
Synthetic methods of azetidinones 
Many methods had been reported for the synthesis of 2-azetidinones in the 
literature.    Some of   those methods were listed in this study. 
a) Ketene-imines Cycloaddition 
The ketene-imines cycloaddition was reported to be a smooth well-
documented route to the synthesis of substituted β - lactam derivatives. In an effort to 
investigate suitably substituted monocyclic β-lactam as a minimum requirement for 
biological activity, many scientists reported the trans-stereoselective synthesis of 
butadienyl azetidinones and their Diels-Alder cycloaddition. This included the 
preparation of a series of Schiff’s bases and their reaction with dienylketene to 
produce a trans-azetidinone .This involved the in situ formation of the ketene and its 
subsequent addition to the imines. (Staudinger H. et al., 1912) 
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R
N H
O
Cl
TEA
CH2Cl2
R
O
R1
R1
H+
 
b) Wasserman Cyclization 
The stability of 2-azetidinones to enzymatic ring opening by β-lactamases was 
studied. They suggested that a halogen ß- to the carbonyl would increase the IR 
absorption of the C=O, one of the criteria of the reactivity of the β-lactam in this 
aspect. Fluorine substitution, which will not introduce a large steric hindrance, is 
particularly interesting for a possible biological effect and possible stability towards 
β-lactamase. β-Bromopropionamide derivative was prepared, which can be cyclized 
by wasserman procedure using sodium hydride to give the N-(3-carboxy-6-
methylphenyl) 3- difluoro-2-azetidinone. (Roger Joyeau. et al., 1988) 
BrCH2COCOOC2H5
SF4
BrCH2CF2COOC2H5 Cl
O
F
F
Br
NH2Ar
H
N
O
F
F
Br
CH3
HOOC
NaH
N
O
F
F
Br
CH3
HOOC  
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c) Synthesis of ß-Lactams from Imidates 
The synthesis of alkoxy β–lactams via acid chloride imine route was reported. 
Imidates such as substituted N-phenyl formimidate, were reacted with acid chlorides 
to produce β-lactam. The major feature of this synthesis is its high stereoselectivity, 
only trans-4-alkoxy- β-lactams were formed. (Cardellini. et al., 1984) 
RO-CH=N-C6H5 X-CH2-COCl
TEA
CH2Cl2
H
OR
H
X
O
+
 
d) Acid Chloride Addition Reaction 
              A method to prepare β-lactams which involved the reaction between 
benzylideneaniline and few selected acid was reported. (Bose. et al., 1995) 
 
XCH3
COCl
+ CHR
NAr
CH2X
OC NAr
CHR
Cl
-
OC NAr
CHR
X+
Cl
-Et3N
OC NAr
CHR
X+
CHR
OC N
X
Ar
-
OC NAr
CH3X R
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1.2.  4-THIAZOLIDINONE 
               4-Thiazolidinones are derivatives of thiazolidine with a carbonyl group at 
the 4-position, has been considered as a moiety of choice as it possesses a broad 
spectrum of pharmacological activities against several targets.  
Structure: 
                                                   
S
N
H
O
 
Molecular formula    : C3H5NOS 
Molecular weight       : 103.143 
Synonyms                  :  1, 3-thiazolidin-4-one 
Physical properties 
Description               : Colourless solid 
Melting point            : 194° C 
Boiling point             : 294.52° C 
Density                      : 1.278 g/cm3 
Molar refractivity     : 25.476 cm3 
Solubility                   : Soluble in ethanol, acetone; insoluble in water 
 Stability                    : Stable under normal temperature and condition 
          4-Thiazolidinone ring also occurs in nature; thus actithiazic acid [(–) 2-(5-
carboxypentyl) thiazolidin-4-one)] isolated from Streptomyces strains exhibits highly 
specific in vitro activity against Mycobacterium tuberculosis. (Saeed. et al., 2007)  
Thiazolidinone derivatives are the subject of renowned interest because they 
have been found to be useful intermediates for the synthesis of various heterocyclic 
compounds. 4-Thiazolidinone derivatives has been considerable interest in the 
chemistry of thiazolidin-4-one ring systems, which is a core structure in various 
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synthetic pharmaceuticals displaying a broad spectrum of biological activities which 
includes anti-inflammatory, anticonvulsant, anti-fungal, anti-thyroid, antitubercular 
and antidiabetic. Antimicrobial activity is the most potent activity of thiazolidine-4-
one. Antibacterial activity is strongly dependent on the nature of substituent at C-2 
and N-3 position. It was also found to possess various other activities such as 
antidiarrheal, antiplatelet activating factor, antihistaminic, antimicrobial, antidiabetic, 
cycloxygenase inhibitory, Ca2+ channel blocker, PAF antagonist, cardioprotective, 
anti ischemic, anti cancer, anti HIV, non-peptide thrombin receptor antagonist and 
Follicle stimulating hormone (FSH) receptor agonist activity and  CFTR inhibitor 
activity. (Mulay abhinit. et al., 2009) 
Synthetic methods of 4-thiazolidinone 
Several methods for synthesis are available in literature which involves 
conventional one pot, two pot synthesis and microwave as well as combinatorial 
syntheses methods. 
a)   The dithiocarbamates formed by the reaction of primary amine with carbon 
disulfide in the presence of base react with haloalkanoic acid in the presence of 
NaHCO3 to give substituted 2-thiono-4- thiazolidinones as presented in the scheme. 
(Cunico W. et al., 2007)                           
            
R
H
N S X
R2
OH
OS
R
H
N S
OH
O
S
S
NO
R2
S
R
R1 + + R1X
 
b) One pot three component synthesis containing aldehyde, thiourea and chloroform 
to give 2-amino-4-thiazolidinone derivatives was also reported. Various imino 
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thiazolidinones were developed by using different reagents with different reaction 
conditions. (Jieping Z. et al., 2004) 
CHO 1) DBU, CHCl3
2) Thiourea
3) NaOH, H2O, DME
53%
S
N
HNH
O
 
c) The synthesis of the 2,3-diaryl-1,3-thiazolidin-4-ones was reported. It was done by 
reacting substituted benzaldehyde with equimolar amount of an appropriate 
substituted aromatic amine in the presence of an excess of mercaptoacetic acid in 
toluene utilizing microwave irradiation. (Sriram D. et al., 2005) 
Ar
-
NH2 + SH COOH +
H
O
R
Toluene
MWI, 6-8 min
80% intencity
S
N
Ar
-
O
R
 
d) A series thiazolidin-4-one was synthesized by the reaction with schiff bases. The 
Schiff bases were synthesized by condensation of aromatic amine with different 
substitute aromatic aldehydes. The obtained Schiff bases were subjected to 
condensation with mercaptoacetic acid to give the corresponding 4-thiazolidinones. 
(Jubie. et al., 2009) 
 
                 
R NH2
ArCHO/EtOH
R N
Ar
-
R N
SO
Ar
-
 
 
e) An efficient tandem procedure for the synthesis of 2-hydrazolyl-4-thiazolidinones 
under microwave conditions was reported. Different solvents and various reaction 
equivalents were explored until good isolated yields of thiazolidinones were obtained. 
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Microwave heating for the synthesis of thiazolidinone  resulted in a significantly 
better yield compared to thermal conditions (75% vs 40%). Microwave irradiation 
also allowed for a faster conversion. For tandem reactions, the best yields were 
obtained when a solvent mixture of PhMe/DMF (1:1) was used. Thiazolidinone was 
prepared in 68% yield using a stepwise sequence and in 82% yield under tandem 
conditions. (Saiz C. et al., 2009) 
   
O
R + NH2 NH NHR1
S
N
S
N
N
R
O
OH
O
R
1
NR
NH NHR
1
S
MW MW
 
 
f) There are also several synthetic protocols for the synthesis of 4-thiazolidinones 
using catalysts like N, N’-dicyclohexylcarbodiimide (DCC), O-(benzotriazol-yl)-
N,N,N’,N’-tetramethyluronium hexaﬂuoro phosphate (HBTU), ferrite, sodium 
sulfate and activated ﬂy ash. The use of microwave heating, solid phase and 
polymer supported systems to run the cyclocondensation leading to 2,3-
disubstitiuted 4-thiazolidinones have also been reported. (Umesh. et al., 2011) 
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S
N
O
CH3
CH3
COOH
RCONH
                 
S
N
O
R(CH2)3CONH
CH2OCOCH3
COOH  
 Penicillin (antibiotic)                                           Cephalosporin (antibiotic) 
 
N
O
O
HHOOC
CH2OH
H
H                              
OH
NH
N
S
O
O
CH3
CH3
NH2
O
OH
 
 
Clavulanic acid (antibiotic)                                  Amoxillicin (antibiotic) 
 
 
 
OCH3
OCH3
H
N
O
N
S
O
COOH               
Cl ON
NH
N
S
O
OCl
COOH                                 
     Methicillin (antibiotic)                                      Dicloxacillin (antibiotic) 
 
 
N
O
HO
O
H3C
OH
S
NH2
H
               
N
O
HO
HO
F
F
     
Thienamycin (antibiotic)                                         Ezetimibe (cholesterol inhibitor) 
 
 
Fig-1: Compounds containing azetidinone nucleus 
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N
N
O
S
NH
O
O            
N
O
S
NHH3C
O
O
H
                  
 Rosiglitazone (antidiabetic)                                      Pioglitazone   (antidiabetic)   
                                                                                 
 
                                
S
HN
O
O
O
          
S
HN
O
O
O
N
N
O
 
        Ciglitazone (antidiabetic)                                       Rivoglitazon (antidiabetic) 
 
S
NH
O
O
O
O
CH3H3C
H3C
CH3
HO
                
HO NH
S
O
NH
 
        Troglitazone (antidiabetic)                                Darbufelone (Anti-inflammatory) 
 
Cl
CH3
NH
O
N
S
O
H3C                                      
S N
CH3
O
S COOH  
Ralitoline (anticonvulsant)       Epalrestat (Aldose reductase inhibitor) 
 
                         
                               Fig-2: Compounds containing thiazolidinone nucleus 
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2. LITERATURE REVIEW 
2.1. Literature review on azetidinone 
2.1.1) The preparation and antimicrobial activity of a series of β-amino-β-lactams was 
reported. These compounds were prepared from the 2+2 cycloaddition of β,β-
disubstituted enamines with aryl isocyanates. Compounds underwent facile β-lactam 
ring fission between aminal carbon atom C4 and the nitrogen N1. The resulting 
formylactanilide derivatives were devoid of antibiotic activity. (Abdulla R.F. et al., 
1975) 
 
              
R1
R2
N
O
H
R3
CH3
CH3
   (Fig: 3)       
 
2.1.2) Some of the novel 2-azetidinone derivatives were synthesized and screened for 
anticonvulsant activity against electroshock and metrazole induced convulsions. The 
compounds showed moderate to good activity. (Peter. et al., 1972) 
NCl
R O
Cl
NCl
R O
(Fig: 4)      R = Benzoyl 
2.1.3) Synthesis of 4-amino-2-(3-(4-methoxyphenyl)-2-oxo-4-phenylcyclobutyl) 
benzoic acid was reported and screened for anti-inflammatory and antimicrobial 
activity. These were obtained by reacting p-nitroanthranilic acid and substituted 
aldehydes to get schiff bases which on treatment with chloroacetic acid obtained 
R1 R2 R3 
H CF3 NMe2 
CH3 Cl 
N O
 
Cl H H 
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different compounds. The compound showed good anti inflammatory and 
antimicrobial activity. (Udupi R.H. et al., 1996)           
COOH
NH2 O
OCH3     (Fig: 5) 
2.1.4) Methyl-2-{2-[3-chloro-4-oxo-1-(4-nitrophenylcarbonylamino)azetidin-2yl]-
phenoxy}-acetate was synthesized and screened for antibacterial activity. The 
compound showed good activity against S. aureus and Salmonella typhi. (Desai N.C. 
et al., 2000) 
CH2COOCH3
N
NH
O
O
Cl
O2N
(Fig: 6) 
2.1.5) A series of N-(2-aryl-3-chloro-4-oxoazetidin-1-yl)-2-(4-methoxyphenylamino) 
acetamides were synthesized from p-anisidine moiety. The structures of the newly 
synthesized compounds were confirmed by IR, 1H NMR and mass spectroscopic 
analysis. The antibacterial and antifungal potential of the synthesized compounds 
were evaluated by the agar disc method. (Ishwar K. et al., 2007) 
                         
O
NH
HN
N
R
O
Cl
OCH3
(Fig: 7) 
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2.1.6) Synthesis, characterization and biological activity of 1,3,4-substituted 2-
azetidinones was reported. All the compounds displayed high to moderate antiviral 
and antifungal activities. (Pandey V.K. et al., 2005) 
          
                        
CO
R
R'
NH
O
Ph
OPh
 (Fig: 8) 
 
 
 2.1.7) N-(3-chloro-2-oxo-4-arylazetidin-1-yl)-2-(4-chlorophenyl) acetamides was 
prepared and evaluated for their antibacterial activity. The compounds showed good 
activity against E.coli and S. aureus in terms of minimum inhibitory concentration. 
Also QSAR studies for the compounds were done for structural and physicochemical 
parameters. (Desai N.C. et al., 2008) 
Cl
NH
O
Cl
Ar
O
    (Fig: 9) 
 Ar = 2-OH, 4-OH, 4-OCH3, 4-Cl, 2-Cl, 4-CH3 
2.1.8) A series of 2-azetidinone derivatives were synthesized from p-anisidine and the 
synthesized compounds were confirmed by physical & spectral analysis. The 
compounds are evaluated for their antimicrobial properties. The activities are due to 
C=O, C-N, linkages in 2-azetidinones. All the compounds showed comparable 
  R          R’ 
  H 
CO
N
CO
 
CH2CH3 
OCHN
 
  H 
N
OCHN
 
 C6H5 OH
OCHN  
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antimicrobial activities. Among these, 2-azetidinone having p-dimethyl amino phenyl 
at 4th position had shown good activity in all the species. (Jubie S. et al., 2009)  
NCH3O
O Cl
Ar
(Fig: 10) 
Ar = phenyl, 2-chlorophenyl, 4-chlorophenyl, 3-chlorophenyl, p-dimethylaminophenyl 
2.1.9) A series of 3-chloro 4-aryl N-pyridine -2-yl 2-azetidinone derivatives were 
prepared and characterized by IR, 1H-NMR and Mass spectral studies. All the 
compounds were subjected to leptospirocidal study and the compounds showed 
significant to moderate activity. (Natarajan Ramalakshmishmi. et al., 2009) 
N N Ar
O Cl      (Fig: 11) 
   Ar = H, 2-OH, 4-OH, 4-OCH3, 4-Cl, 2-Cl, 4-CH3, 4-N (CH3)2, 3-NO2, 4-NO2 
2.1.10)  A series of 3-thiolated β-lactams were synthesized. All the compounds were 
characterized by spectral data and elemental analysis and were evaluated for their 
in vitro antibacterial and antifungal activities against various pathogenic strains. The 
preliminary screening results indicated that some of these compounds demonstrated 
moderate to very good antibacterial and antifungal activities. (Maaroof Zarei. et al., 
2011)   
N
O
S
R3
R1
R2
 (Fig: 12) 
 
    R1 R2 R3 
4-NO2C6H4 4-MeOC6H4 C6H5 
4-NO2C6H4 4-ClC6H4 C6H5 
4-NO2C6H4 Me C6H5 
C6H5CH2 4-MeOC6H4 C6H5 
C6H5CH2 4-ClC6H4 C6H5 
C6H5CH2 Me C6H5 
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2.1.11) Some of the 2-azetidinone derivatives from 2-aminopyridine were synthesized. 
Structures of synthesized compounds were confirmed by physical and spectral analysis. 
The compounds are evaluated for their antimicrobial activities. The activities are due to 
cyclic CO-NH group in azetidinones. The following compounds showed significant 
activity against all the microbial strains. (Bijo Mathew. et al., 2010) 
                  
                      
N
O Cl
N
R1
R2
R3
(Fig: 13) 
2.1.12) A number of 2-azetidinone were synthesized and characterized. The compounds 
were found to possess good anticonvulsant activity in rats. The simultaneous presence of 
one aromatic and one aliphatic radical at R and R’ was necessary for high activity, 
showed activity similar to that of Phenobarbital. (Maffi. et al., 1959) 
N
R
R1O
R2
(Fig: 14) 
R = H, CH3, C2H5, C6H5, p-NO2 C6H5, p-NH2 C6H5;  
R1 = Ph, PhCH2; R2 = H, CH3, C2H5 
2.1.13) A novel series of 2, 4-azetidinone compounds were synthesized and the 
compounds were tested for mycostatic, bacteriostatic and CNS activity. (Testa. et al., 
1963) 
R1 R2 R3 
H H Cl 
OH H H 
H OCH3 H 
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N
R2
O
O
R1R
 (Fig: 15)         R = H; R1 = cyclohexyl; R2 = H 
2.1.14) An efficient use of triphosgene, as an acid activator, for the synthesis of 
substituted 2-azetidinones via ketene-imine cycloaddition reaction using acids and 
imines was reported. (Krishnaswamy D. et al., 2002) 
N
R2O
R1 R3
H
H
  (Fig: 16) 
2.1.15) A novel adamantine derivative of 2-azetidinone was synthesized and tried its 
activity against influenza virus A-PR8 and hepatitis virus MHV3 and obtained 
encouraging results. (Levinine. et al., 1971) 
N
O
 (Fig: 17) 
2.2. Literature review on thiazolidinone 
2.2.1) A series of 2, 3-diaryl-1,3-thiazolidin-4-one derivatives were synthesized and 
characterized. Among them the compound 2-(2, 6-dimethylphenyl)-3-
phenylthiazolidin-4-one was found to be most potent and reported as a new family of 
anti-viral agents acting as NNRTIs with minimal cytotoxicity. It was found that 
substitution by aryl group at nitrogen atom increases the cytotoxic activity of 
compound. (Monforte. et al., 2001) 
18 
  
N S
CH3CH3
O (Fig: 18) 
2.2.2) 2-adamantyl-substituted thiazolidin-4- one derivative was synthesized and 
evaluated for its activity against HIV-1 (IIIB) and HIV-2(ROD) in CEM cell cultures, 
by taking Nevirapine as reference compound. Among them compound (19) was found 
to be more potent. Substitution by admantyl at second position was found to shown 
increased in cytotoxic activity. (Balzarini. et al., 2007) 
N
S
O
CH3
(Fig: 19) 
2.2.3) A series of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-one 
derivatives were designed, synthesized and evaluated as selective HIV-1 RT enzyme 
inhibitors. The substitution of aryl group at nitro atom showed increased in cytotoxic 
activity. (Rawal. et al., 2008) 
N S
BrBr
O (Fig: 20) 
2.2.4) A series of 2-amyl-4-oxothiazolidin-3-yl amides were synthesized and these 
were evaluated for their ability to inhibit prostate cancer cell. Few potent compounds 
were detected, which were effective in killing prostate cancer cells with improved 
selectivity compared to serine amide phosphates. The Compound (21) was found to 
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be most potent. It was found that substitution at nitrogen atom by long alkyl chain 
causes increase in anticancer activity. (Gududuru. et al., 2004) 
N
S
ONH2
CH3
O
(Fig: 21) 
2.2.5) The synthesis and pharmacological activity of 5-arylidene-2-imino-4-
thiazolidinone derivatives was reported. All the derivatives exhibited significant 
activity levels in models of acute inflammation such as carrageenan-induced paw and 
pleurisy edema in rats, by taking indomethacin as standard drug. In particular, 5-(3-
methoxyphenylidene)-2-phenylimino-3-propyl-4-thiazolidinone displayed high levels 
of carrageenan-induced paw edema inhibition comparable to those of indomethacin. 
(Ottana. et al., 2005) 
N
S
O
N
H5C6
C3H7
Ar
(Fig: 22) 
Ar= 3-CH3OC6H4, 4-CH3S C6H4, 4- CH3SO2C6H4, 4-CH3OC6H4, 4-ClC6H4, 3, 4-
(CH3O)2C6H4 
2.2.6) A new series of thiazolidine-4-one derivatives were synthesized and evaluated 
for anti-inflammatory, analgesic and anti-ulcer activity by carrageenan-induced paw 
edema test, acetic acid induced writhing method and pylorus ligation ulcer model 
respectively. All the compounds showed significant anti-inflammatory, analgesic and 
anti-ulcer activity at 100 mg/kg b.w. (Taranalli. et al., 2009) 
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S
NO
OH
R
3
R
2
R
1
R
(Fig: 23) 
                                                                 
2.2.7) Synthesis and antifungal activity of 4-thiazolidinones derived from ethyl 
vanillin was reported. The synthesized compounds were characterized on the basis of 
elemental analysis and spectral studies and compounds were screened for antifungal 
activity. (Manrao M.R. et al., 1995) 
N
S
R
O
OH
H5C2O
R1 (Fig: 24) 
R=H, Me, OMe, OEt, Cl 
2.2.8) 2-Phenyl-2-methyl-3-aryl thiazolidin-4-ones had prepared by the addition of 
thioglycollic acid to substituted azomethines in benzene. The compound was reported 
for good antibacterial activity. (Shukla H.K. et al., 1981) 
N
S
CH3
COOH
O (Fig: 25) 
 
2.2.9) A series of new N-type calcium channel blockers derived from the ‘hit’ 
structures 2-(3-bromo-4-fluorophenyl)-3- (2-pyridin-2-ylethyl) thiazolidin-4-one and 
its 2-[4-(4-bromophenyl)pyridin-3-yl]-3-isobutyl analogue were synthesized. By SAR 
the compound have been identified as the most potent compounds in this series. These 
R  R1  R2  R3 
H H H H 
H OCH3 H H 
H CH3 H H 
H CH3 CH3 NH3 
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compounds show promise as lead structures in the quest for clinically effective N-type 
blockers in the treatment of pain. (Lars. et al., 2007) 
S N
O
N
H3C CH3
CH3 (Fig: 26) 
 
2.2.10) 2-thioxo-4-thiazolidinone (rhodanine) derivatives are potential inhibitors of 
HIV integrase. These structures have been found to impart antitumor properties such 
as seen in rhodacyanine dyes. Moiety is an important structural scaffold for Integrase 
inhibitory activity. Such derivatives are suitable leads for antiviral and anticancer drug 
development. (Kavya Ramkumar. et al., 2010) 
N
H
S
SO
(Fig: 27) 
2.2.11) A novel synthesis of thiazolidine-2-thione and thiazolidine-2-one derivatives 
was described with the iodo-cyclosthiocarbamation reaction as the key step for the 
heterocyclic ring formation. This new method is applied to the synthesis of 
thiazolidinones as bioisosteric analogs of Linezoid and the antimicrobial properties of 
synthesized compounds were reported. (Viswajanani Sattigeri. et al., 2005) 
H3C
O
N
H
S
N
O
O
CH3
(Fig: 28) 
2.2.12) A series of 1,3-thiazolidin-4-ones bearing various substituted diaryl ring at C-
2 and N-3 positions were synthesized and evaluated for their anti-YFV activity.the 
compounds showed  inhibitory effects on the replication of YFV in green monkey 
kidney (Vero) cells (ATCC CCL81), by means of a cytopathic effect reduction assay. 
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The synthesized compounds were found to be more effective than rabavirin and 
showed potent anti-YFV agent. (Dharmarajan. et al., 2005) 
 
S
N
O
Ar
R
(Fig: 29) 
 
2.2.13) A series of 4-thiazolidinone were synthesized and evaluated for their anti-
inflammatory, analgesic, anticonvulsant and antimicrobial activity. All the 
compounds showed good biological activities. (Seema Mishra. et al., 1997) 
N
S R1
O
R
             (Fig: 30) 
2.2.14) Synthesis and anti-HIV activity of a series of 2,3-diaryl-1,3-thiazolid-4-ones 
were reported. The compounds exhibited moderate to good activity. (Barreca M.L. et 
al., 2001) 
S
N
Ph
Ph
O
    (Fig: 31) 
2.2.15) A series of 4-thiazolidinone derivatives were synthesized and the structure of 
the synthesized compounds were confirmed on the basis of IR and H-NMR. The 
synthesized compounds were screened for anti-inflammatory activity. Among the test 
compounds, III showed promising anti-inflammatory activity as compared to the 
control. (Vaidya. et al., 2011)  
 
Code Ar R 
DS1 4-F-C6H4 4-Cl 
DS2 4-F- C6H4 2-Cl 
DS3 4-F- C6H4 3-NO2 
DS4 2-C5H4N 4-Cl 
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S
N
R1
R2
R3O (Fig: 32) 
2.2.16)  A novel derivatives of 4-thiazolidinone were prepared from biphenyl-4-carboxylic 
acid and evaluated for their in vitro antimicrobial activity against two gram negative 
strains (E. coli and P. aeruginosa) and two gram positive strains (B. subtilis and S. 
aureus) and fungal strain C.albicans and A. niger. The results revealed that all synthesized 
compounds have a significant biological activity against the tested microorganisms. 
(Aakash Deep. et al., 2011) 
 
NH
N
S
O
O
Ar-
Ar'   (Fig: 33) 
Ar= 3-BrC6H4; Ar’= 3-NO2 C6H4, 3-BrC6H4 
2.2.17) Some new series of 3-(substituted phenyl)-2-methyl-2-p-tolylthiazolidin-4-ones 
were prepared from 1-p-tolylethanone. The titled compounds were characterized on the 
basis of elemental analysis, IR, 1H-NMR and 13C-NMR spectral data. All the 
synthesized compounds were screened against four different bacterial strains S. aureus, 
S. paratyphi-A, B. subtilis and fungal strain F. molaniforme and A. niger. Some of them 
showed good antibacterial and antifungal activity compared to reference drugs used in 
the study. (Vikas A. Desai. et al., 2011) 
Code R1 R2 R3 
I 4-NO2 4-F 3-Cl 
II 4-NO2 4-Br H 
III 4-SCH3 4-OCH3 H 
IV 4-SCH3 4-CF3 H 
V 4-OCH3 H 3- CF3 
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N
S
O
H3C
R
(Fig: 34) 
R= 4-Fluoro; 2, 4-difluoro; 3,5-difluoro; 2-methoxy; 3-Bromo 
2.3. Literature review on azetidinone and thiazolidinone 
2.3.1) A series of schiff’s bases, 2-azetidinones, 4-thiazolidinones derivatives of the 
para aminosalicylic acid were synthesized. It was planned to employ the structure 
based computer aided drug designing (CADD) to schiff base, 2-azetidinone (Fig-35) 
and 4-thiazolidinone (Fig-36) of para aminosalicylic acid. Based on the data obtained 
from ligand-receptor binding studies, the novel molecules were synthesized and 
evaluated for their in vitro antimicrobial activity against Staphylococcus aureus, 
E.coli, candida albicans and Aspergillus nigar. The structure of synthesized 
compounds had established on the basis of their spectral (IR, 1H NMR and mass) data. 
(Wadher S.J. et al., 2009) 
                                 
OHO
OH
N
O
R
Cl
      (Fig: 35)           
OHO
S
N OR
OH
(Fig: 36) 
R= phenyl, 4-methoxyphenyl, 4-hydroxyphenyl 
2.3.2) Synthesis of some azetidin-2-ones and thiazolidin-4-ones as potential 
antimicrobial agents were reported. 3-chloro-4-(substituted phenyl)-1-(3’-bromo-4’-
methoxybenzamido)azetidin-2-ones (37) and 2-(substituted phenyl)-3-(3’-bromo-
4’methoxy benzamido)thiazolidin -4-ones (38) were synthesized. The structure of the 
newly synthesized compounds was established by analytical spectral data. These  
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compounds were screened for their biological activity. (Havaldar Freddy H. et al., 
2004)  
Br
H3CO CONH N
Cl
O Cl (Fig: 37) 
Br
H3CO CONH
Cl
S
N
O (Fig: 38) 
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3. AIM AND PLAN OF WORK 
Aim: 
      The chemistry of heterocyclic compounds continues to be an active field in the 
organic chemistry. Much attention has paid to the synthesis of heterocyclic 
compounds bearing nitrogen and sulphur containing ring systems like azetidin-2-
ones and thiazolidin-4-ones. This may be mainly due to their wide range of 
biological activities. The synthesis of above class of compounds provides an 
outstanding case of modern drug development and also emphasizes the biological 
activity from structure modification to protype of drug molecules. 
    From the literature survey, it reveals substituent in the azetidinone and 
thiazolidinone may be varied, but the greatest difference in structure and 
properties is exerted by the group attached to the carbon atom in the 4th position of 
azetidinone and the 2, 3, and 5-position of thiazolidin-4-none. Hence it shows, 
slight modification in structure can result in quantitative as well as qualitative 
changes in activity. 
      Since bulky substitution at all positions of 2-azetidinone and 4-thiazolidinone 
were reported and known to possess various biological activities such as 
antimicrobial, anti-inflammatory, analgesic activities, in the literature review.  
So, in the present study, we decided to synthesize a new series of azetidin-2-
one and thiazolidin-4-one compounds with simple substitution and to screen the 
newly synthesized compounds for their anti antimicrobial, analgesic and anti-
inflammatory activity.   
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Plan of work: 
 Synthesis of the following by appropriate method as per literature. 
 Schiff bases of p-amino benzoic acid  
 2-Azetidinone derivatives 
 4-Thiazolidinone derivatives 
 Characterization of the newly synthesized compounds by  
                         Physical data such as 
 Solubility  
 Melting point 
 Thin layer chromatography 
          Characterization and interpretation by  
 UV  Visible Spectroscopy 
 IR Spectroscopy 
 1H-NMR Spectroscopy 
 Mass   Spectroscopy 
 To evaluate the antimicrobial activities for synthesized 2-azetidinone and 4-
thiazolidinone derivatives. 
   To screen the following biological activities only for the synthesized 4-
thiazolidinone derivatives (SS5 & SS6): 
 Anti-inflammatory activity- Carrageenan induced paw edema method 
 Analgesic activity- Eddy’s hot plate method  
 
 
  
EXPERIMENTAL 
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4. EXPERIMENTAL 
4.1 Materials 
List of chemicals and drugs used: 
S.No. Chemicals/Drugs Manufacturers 
1 p-amino benzoic acid Loba Chemie Pvt. Ltd., Mumbai 
2 p-hydroxy benzaldehyde Loba Chemie Pvt. Ltd., Mumbai 
3 p-dimethyl benzaldehyde Loba Chemie Pvt. Ltd., Mumbai 
4 p-nitro benzaldehyde Loba Chemie Pvt. Ltd., Mumbai 
5. Ethanol Loba Chemie Pvt. Ltd., Mumbai 
6. Glacial acetic acid Qualigens Fine Chemicals, Mumbai 
7 Thioglycollic acid Qualigens Fine Chemicals, Mumbai 
8 Dioxane Loba Chemie Pvt. Ltd., Mumbai 
9. Dimethyl formamide Loba Chemie Pvt. Ltd., Mumbai 
10. Chloroacetyl chloride Loba Chemie Pvt. Ltd., Mumbai 
11. Triethylamine Qualigens Fine Chemicals, Mumbai 
13. Carrageenan  Sodium Sigma Chemical Co., USA 
14. Diclofenac sodium German Remedies, Mumbai 
15. Benzene  Qualigens Fine Chemicals, Mumbai 
16. Acetone  Loba Chemie Pvt. Ltd., Mumbai 
17. Zinc chloride Loba Chemie Pvt. Ltd., Mumbai 
18. Polyethylene glycol Spectrochem Pvt. Ltd., Mumbai 
19. Ciprofloxacin Hi-media Pvt. Ltd., Mumbai 
20. Ketoconazole Hi-media Pvt. Ltd., Mumbai 
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List of instruments used: 
S.no Instruments Manufacturer 
1. Melting point apparatus Elico Ltd., Hyderabad 
2. Digital electronic balance Shimadzu Ax - 200 
3. Heating Mandle Ajay Thermo Electrics., Chennai 
4. UV-Visible 
spectrophotometer 
Shimadzu 1601 UV-spectrophotometer, 
Japan 
5. 1H-NMR spectrophotometer JEOL JNM-α 400 spectrometer 
6. FT-IR spectrophotometer Shimadzu FTIR-8101 spectrophotometer 
7. Mass spectrophotometer Jeol SX102/DA-6000 mass spectrometer 
8. Hot air oven Precision Scientific Co., Chennai. 
9. Hot plate Instrumental and Chemical Pvt. Ltd., 
10. Plethysmometer Inco rat paw Plethysmograph mercury 
model, Ambala, India. 
 
Microorganisms: 
The gram positive bacteria (Staphylococcus aureus ATCC 25923), gram 
negative bacteria (Escherichia coli ATCC 25922) and fungal strain (Candida albicans 
ATCC 2091) were collected from Microbial Resources Division, Kings Institute of 
Preventive Medicine, Guindy, Chennai. The agar medium was purchased from HI-
media Laboratories Ltd., Mumbai, India. 
Animals: 
All the animals (albino mice and wistar albino rats, of either gender) were obtained 
from the Kings Institute of Preventive Medicine, Guindy, Chennai. Animals were 
housed in animal house in Adhiparasakthi College of Pharmacy in standard 
environmental conditions of temperature (25±20º C), humidity (55±10%) and light 
(12:12 hour light: dark cycle). The animals were fasted prior to dosing but water was 
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given ad-libitum. The anti-inflammatory and analgesic activity was carried out as per 
CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on 
Animals) guidelines after obtaining the approval from the Institutional Animal Ethical 
Committee. 
ANALYTICAL TECHINQUE 
Physical data 
Melting point of the synthesized compounds were taken in the open capillary tubes. 
Thin layer chromatography (TLC) 
Purity of the compounds was checked by thin layer chromatography using silica gel G 
as stationary phase and benzene and acetone as mobile phase. The spot resolved were 
visualized by using iodine chamber. 
UV spectra 
The UV spectra of the synthesized compounds were recorded in the range of 200-
400cm-1 and the absorbance maximum are reported in cm-1 at Adhiparasakthi College 
of Pharmacy. 
Infrared spectra 
The IR spectra were recorded on Fourier Transform IR spectrometer in the 
range of 400-4000cm-1 using KBr pellets and values of vmax are reported in cm-1 at 
Ideal Analytical and Research Institution, Puducherry. 
1H NMR spectra 
1H NMR spectra were recorded on DPX-400 MHz NMR spectrometer using DMSO-
d6 and chemical shift (δ) are reported in parts per million downfield from internal 
reference tetramethylsilane (TMS) at Sophisticated Analytical Instrumentation 
Facility, Panjab University, Chandigarh 
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Mass spectra 
Mass spectra of the synthesized compounds were recorded at Sophisticated 
Analytical Instrumentation Facility, Indian Institute of Technology, Madras.  
4.2 Methodology: 
Monitoring of Synthetic Reaction Procedures: 
Established synthetic procedures were employed for synthesis of compounds RS1 to 
RS10 and the reactions were monitored by Thin Layer Chromatography (TLC) employing 
6’’ X 2’’ plates coated with 0.25 mm thick layer of silica gel (pre-activation by heating at 
110°C for one hour). Solvent systems of varying polarity ranging from benzene to benzene 
to acetone mixtures (9:1, 5:5, 8:2, 7:3, 6:4, and 4:6) were used to monitor the reactions. The 
plates were visualized in iodine chamber. 
Purification Techniques: 
Recrystallization: The crude products were recrystallized in appropriate solvent. 
Single solvent was used wherever possible and solvent mixtures were not used anywhere.  
Authentication of Chemical Structures and Purity of Compounds: 
Chemical structure of products and their purity were ascertained by thin layer 
chromatography, UV-visible spectrometer, melting point and various spectral techniques 
including Fourier Transform Infra Red Spectroscopy, Nuclear Magnetic Resonance 
Spectroscopy, Mass Spectroscopy and Ultra Violet Spectrophotometer. 
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4.3. SYNTHESIS OF COMPOUNDS 
4.3.1. Synthesis of 4-[4-(dimethylamino benzylidene) amino] benzoic acid (SB1) 
1.23 g (0.01 mol) of p-amino benzoic acid was dissolved in 30 ml ethanol containing 
few drops of glacial acetic acid. 1.49 g (0.01mol) of p-dimethylamino benzaldehyde 
was added to the reaction mixture and stirred well. The reaction mixture was refluxed 
for 3 to 5 h, cooled and then poured into crushed ice .The solid obtained was filtered, 
washed with water and recrystallized from ethanol. (Jubie S. et al., 2009) 
              
+
4-aminobenzoic acid 4-(dimethylamino)benzaldehyde
O
N
H
CH3
CH3O
OH
NH2
C2H5OH
CH3COOH
O
OH
N
N
CH3
CH3
 
Scheme-1: Synthesis of 4-[4-(dimethylamino benzylidene) amino] benzoic acid 
 
4.3.2. Synthesis of 4-[4-(nitrobenzylidene)amino]benzoic acid (SB2) 
1.23 g (0.01 mol) of p-amino benzoic acid was dissolved in 30 ml ethanol containing 
few drops of glacial acetic acid. 1.15 g (0.01 mol) of p-nitro benzaldehyde was added 
to the reaction mixture and stirred well. The reaction mixture was refluxed for 3 to 5 
h, cooled and then poured into crushed ice .The solid obtained was filtered, washed 
with water and recrystallized from ethanol.  
 
+
4-aminobenzoic acid 4-nitrobenzaldehyde        4-(4-nitrobenzylideneamino)benzoic acid
O
NO2
HO
OH
NH2
C2H5OH
CH3COOH
O
OH
N
NO2
 
Scheme-2: Synthesis of 4-[4-(nitrobenzylidene) amino] benzoic acid 
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4.3.3. Synthesis of 4-[4-(hydroxybenzylidene) amino] benzoic acid (SB3) 
1.23 g (0.01 mol) of p-amino benzoic acid was dissolved in 30 ml ethanol containing 
few drops of glacial acetic acid. 1.22 g (0.01 mol) of p-hydroxybenzaldehyde was 
added to the reaction mixture and stirred well. The reaction mixture was refluxed for 
3 to 5 h, cooled and then poured into crushed ice .The solid obtained was filtered, 
washed with water and recrystallized from ethanol.  
 
+
4-aminobenzoic acid  4-hydroxybenzaldehyde
O
H
OH
O
OH
NH2
C2H5OH
CH3COOH
O
OH
N
OH
   4-(4-hydroxybenzylideneamino)benzoic acid
 
 Scheme-3: Synthesis of 4-[4-(hydroxybenzylidene) amino] benzoic acid 
 
4.3.4. Synthesis of 4-(3-chloro-2-(4-dimethylaminophenyl)-4-oxoazetidin-1-yl) 
benzoic acid (SS1) 
To a solution of appropriate amount of 4-[(4(dimethylamino)benzylidene)amino] 
benzoic acid  (0.01 mol) in Dioxane (15 ml), triethyl amine (0.02 mol) was added. To 
this, a solution of chloroacetyl chloride (0.02 mol) was added in portion wise with 
vigorous shaking at room temperature for 20 min and heated under reflux for an 3 h 
and the content was kept at room temperature for 48 h. The azetidinone compounds, 
which separated on dilution with ice cold water was collected, dried and recrystallized 
from ethanol. (Raga Basawaraj. et al., 2010) 
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4-(4-(dimethylamino)
benzylideneamino)benzoic acid 4-(3-chloro-2-(4-(dimethylamino)phenyl)-
4-oxoazetidin-1-yl)benzoic acid
O
OH
N
N
CH3
CH3
O
OH
N
O
N
Cl
CH3CH3
ClCH2COCl / (C2H5)3N
reflux for 3 h
 
Scheme-4: Synthesis of 4-(3-chloro-2-(4-dimethylaminophenyl)-4-oxoazetidin-1-yl) 
benzoic acid 
 
4.3.5. Synthesis of 4-(3-chloro-2-(4-nitrophenyl)-4-oxoazetidin-1-yl) benzoic acid 
(SS2) 
To a solution of appropriate amount of 4-[4-(nitrobenzylidene)amino]benzoic acid 
(0.01 mol) in Dioxane (15 ml), triethyl amine (0.02 mol) was added. To this a solution 
of chloroacetyl chloride (0.02 mol) was added in portion wise with vigorous shaking 
at room temperature for 20 min and heated under reflux for an 3 h and content was 
kept at room temperature for 48 h. The azetidinone compounds, which separated on 
dilution with ice cold water was collected, dried and recrystallized from ethanol. 
4-(4-nitrobenzylideneamino)
benzoic acid 4-(3-chloro-2-(4-nitrophenyl)-
4-oxoazetidin-1-yl)benzoic acid
O
OH
N
NO2 O
OH
N
O
NO2
Cl
ClCH2COCl / (C2H5)3N
reflux for 3 h
 
Scheme-5: Synthesis of 4-(3-chloro-2-(4-nitrophenyl)-4-oxoazetidin-1-yl)  
benzoic acid 
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4.3.6. Synthesis of 4-(3-chloro-2-(4-hydroxyphenyl)-4-oxoazetidin-1-yl) benzoic 
acid (SS3) 
To a solution of appropriate amount of 4-[4-(hydroxybenzylidene) amino]benzoic 
acid (0.01 mol) in Dioxane (15 ml), triethyl amine (0.02 mol) was added. To this a 
solution of chloroacetyl chloride(0.02 mol) was added in portion wise with vigorous 
shaking at room temperature for 20 min and heated under reflux for an 3 h and 
content was kept at room temperature for 48 h. The azetidinone compounds, which 
separated on dilution with ice cold water was collected, dried and recrystallized from 
ethanol. 
4-(4-(hydroxybenzylideneamino)
benzoic acid 4-(3-chloro-2-(4-(hydroxyphenyl)-
4-oxoazetidin-1-yl)benzoic acid
O
OH
N
OH O
OH
N
O
Cl
OH
ClCH2COCl / (C2H5)3N
reflux for 3 h
 
Scheme-6: Synthesis of 4-(3-chloro-2-(4-hydroxyphenyl)-4-oxoazetidin-1-yl)  
benzoic acid 
 
4.3.7. Synthesis of 4-(2-[4-(dimethylamino)phenyl]-4-oxo-1,3-thiazolidin-3yl)-
benzoic  acid (SS4) 
A mixture of 3.42 g (0.01 mol) of 4-[(4-(dimethylamino)benzylidene)amino]benzoic 
acid (0.01 mol) and mercaptoacetic acid (0.012 mol) was dissolved in 25 ml of 
dimethyl formamide. To this a pinch of anhydrous zinc chloride was added and then 
refluxed for 8 h. The reaction mixture was allowed to cool and poured into ice-cold 
water. The resulting solid was filtered, washed several times with water and 
recrystallized from ethanol. (Deepak Pareek A. et al., 2011) 
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O
OH
N
N
CH3
CH3
+
OH
SH
O DMF / ZnCl2
reflux for 8 h O
OH
N
S
O
N
CH3CH3
4-(4-(dimethylamino)
benzylideneamino)benzoic acid 2-mercaptoacetic acid 4-(2-(4-(dimethylamino)phenyl)-4-
oxothiazolidin-3-yl)benzoic acid
 
Scheme-7: Synthesis of 4-{2-[4-(dimethylamino)phenyl]-4-oxo-1,3-thiazolidin-3-
yl}benzoic acid 
 
4.3.8. Synthesis of 4-{2-[4-nitrophenyl]-4-oxo-1,3-thiazolidin-3-yl}benzoic acid 
(SS5) 
A mixture of 3.44 g (0.01 mol) of 4-[4-(nitrobenzylidene)amino]benzoic acid (0.01 
mol) and mercaptoacetic acid (0.012 mol) was dissolved in 25 ml of dimethyl 
formamide. To this a pinch of anhydrous zinc chloride was added and then refluxed for 
8 h. The reaction mixture was allowed to cool and poured into ice-cold water. The 
resulting solid was filtered, washed several times with water and recrystallized from 
ethanol. 
O
OH
N
NO2 + OH
SH
O DMF / ZnCl2
reflux for 8 h O
OH
N
S
O
NO2
4-(4-nitrobenzylideneamino)
benzoic acid 2-mercaptoacetic acid 4-(2-(4-nitrophenyl)-4-
oxothiazolidin-3-yl)benzoic acid
 
Scheme-8: Synthesis of 4-{2-[4-nitrophenyl]-4-oxo-1, 3-thiazolidin-3-yl} 
 benzoic acid 
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4.3.9. Synthesis of 4-{2-[4-hydroxyphenyl]-4-oxo-1, 3-thiazolidin-3-yl}benzoic 
acid (SS6) 
A mixture of 3.14 g (0.01 mol) of 4-[4-(hydroxybenzylidene) amino] benzoic acid 
(0.01 mol) and mercaptoacetic acid (0.012 mol) was dissolved in 25 ml of dimethyl 
formamide. To this a pinch of anhydrous zinc chloride was added and then refluxed 
for 8 h. The reaction mixture was allowed to cool and poured into ice-cold water. The 
resulting solid was filtered, washed several times with water and recrystallized from 
ethanol.  
O
OH
N
OH +
OH
SH
O DMF / ZnCl2
reflux for 8 h O
OH
N
S
O
OH
4-(4-hydroxybenzylideneamino)
benzoic acid 2-mercaptoacetic acid 4-(2-(4-hydroxyphenyl)-4-
oxothiazolidin-3-yl)benzoic acid
 
Scheme-9: Synthesis of 4-{2-[4-hydroxyphenyl]-4-oxo-1, 3-thiazolidin-3-yl}  
benzoic acid 
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5. BIOLOGICAL SCREENING 
5.1. Evaluation of antimicrobial activity 
                 The antimicrobial screening of the synthesized compounds (SS1-SS6) were 
carried out by determining the zone of inhibition using disc diffusion method. The 
synthesized compounds were dissolved in DMSO and sterilized by filtering through 
0.45 μm millipore filter. Final inoculums of 100 µl suspension containing 108 CFU/ 
ml of each bacterium and fungus used.  Nutrient agar (anti bacterial activity) and 
sabouraud dextrose agar medium (antifungal activity) was prepared and sterilized by 
an autoclave (121 º C and 15 lbs for 20 min) and transferred to previously sterilized 
petridishes (9 cm in diameter). After solidification, petriplates were inoculated with 
bacterial organisms in sterile nutrient agar medium at 45o C, and fungal organism in 
sterile sabouraud dextrose agar medium at 45o C in aseptic condition. Sterile 
whatmann filter paper discs (previously sterilized in U.V. lamp) were impregnated 
with synthesized compounds at a concentration of 25,100 μg/discs was placed in the 
organism-impregnated petri plates under sterile condition. The plates were left for 30 
min to allow the diffusion of compounds at room temperature. Antibiotic discs of 
ciprofloxacin (100 µg/disc) and   ketaconazole (100 µg/disc) were used as positive 
control, while DMSO used as negative control. Then the plates were incubated for 24 
h at 37±1o C for antibacterial activity and 48 h at 37±1o C for antifungal activity. The 
zone of inhibition was calculated by measuring the minimum dimension of the zone 
of no microbial growth around the each disc. (Jubie S. et al., 2009) 
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5.1.a. Acute oral toxicity studies 
The acute oral toxicity studies of synthesized compounds (SS5 & SS6) were 
performed to study the acute toxic effects and to determine minimum lethal dose of 
the drug extracts LD50. Swiss albino mice of either sex weighing 20-25 g were used 
for the study. The animals were fasted overnight prior to the experiment and were 
then grouped (3 mice per group). They were treated intraperitoneally with different 
doses of the test compounds (5, 50, 300 mg/kg). After administration of the 
compounds, animals were observed continuously for the first three hours for any toxic 
manifestation. The animals were then observed for 48 h. Further the animals were 
under investigation up to a period of one week. (Hussain K. et al., 2005) 
 
5.2. Evaluation of Anti-inflammatory activity 
 
           The anti-inflammatory activity of the synthesized derivative (SS5 & SS6) was 
evaluated by carrageenan induced paw edema method.  
          Wister rats of either sex (150-200 g) were randomly selected and the animals 
were divided into control, standard and test groups, each consisting of three animals. 
The first group was treated with 1% polyethylene glycol which served as control, 
second group was administered with a dose of 20 mg/kg  diclofenac sodium 
intraperitoneally which served as standard and other groups III and IV were treated 
with 50 mg/kg of SS5 and SS6 respectively by intraperitoneal route. After 30 min, the 
rats were injected with 0.1 ml of carrageenan (1% w/v) to the sub plantar region of 
left paw of the rats. The volume of paw was measured using mercury displacement 
technique with the help of plethysmograph both in control and animals treated with 
standard and test compounds at 0, 1, 2 and 3 h after injection of carrageenan. 
The percentage inhibition of oedema was calculated by using formula,  
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Percentage reduction =
Vo - Vt
Vo
X 100
 
   Where Vt = mean paw volume of the test drug 
               Vo = mean paw volume of the control 
From the data obtained, the mean odema volume and percentage reduction in odema 
was calculated. (Gurupadyya. et al., 2008) 
5.3. Evaluation of analgesic activity 
         The analgesic activity of the synthesized derivatives (SS5 & SS6) was evaluated 
by Eddy’s hot plate method.  Albino mice of either sex (20-25 g) were randomly 
selected and the animals were divided into control, standard and test groups, each 
consisting of three animals. The first group was treated with 1% polyethylene glycol  
suspension which served as control, second group was administered with pentazocine 
in the dose of 20 mg/kg , intraperitoneally which served as standard and other groups 
were treated intraperitoneally with 50 mg/kg of  test compounds in polyethylene 
glycol.  The animals were placed on hot plate and the pain was induced by 55o C heat 
and the reaction time that is paw licking or  jump response which ever appears was 
recorded  at 0, 30, 60, 90 and 180 min after the drug administration. As soon as 
response was shown the animals are withdrawn from the plate immediately. The cut 
off period of 15sec was maintained to avoid damage to the paw. (Srivastava S.K. et 
al., 2006) 
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6. RESULTS AND DISCUSSION 
6.1. Synthetic Scheme 
2-Azetidinones and 4-thiazolidinones are the most common and important 
groups among the small ring heterocyclic compounds. Many methods had been 
reported in the literature for the synthesis of 2-azetidinone such as ketene-imine 
cycloaddition, wasserman cyclization, acid chloride addition reaction and also by 
using microwave irradiation method. Among these Staudinger ketene-imine 
cyclization is the most common method which involves the reaction of Schiff base 
(imines) with acid chloride in the presence of tertiary base. (Mrunmayee Toraskar. et 
al., 2010) 
         Several synthetic protocols for 4-thiazolidinones are reported in the literature 
such as conventional one pot, two pot, microwave as well as combinatorial synthesis. 
The most common method used was the reaction between Schiff bases (imines) with 
mercaptoacetic acid to form 4-thiazolidinones. (Mulay Abhinit. et al., 2009) 
In this present study, a series of 2-azetidinone and 4-thiazolidinone were 
synthesized by the following strategy: initially Schiff bases (SB1-SB3) was 
synthesized by the condensation of p-amino benzoic acid with three different aromatic 
aldehydes. Cyclo-condensation of Schiff bases with chloroacetyl chloride in the 
presence of tri ethylamine resulted in the formation of corresponding azetidinone 
analogues (SS1-SS3). Similarly cyclocondensation of Schiff base with mercapto acetic 
acid yielded the corresponding thiazolidinone analogues (SS4-SS6).   
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COOH
NH2
+
CHO
R
COOH
N CH R
COOH
N R
O Cl
COOH
N
S
O
R
Substituted benzaldehyde
Schiff base 
2-Azetidinone 
4-Thiazolidinone 
4-aminobenzoic acid
C2H5OH
CH3COOH
3 to 5 hrs
ClCH2COCl SHCH2COOH
8 hrs
/ (C2H5)3N
3 to 5 hrs
(SB1-SB3)
(SS1-SS3)
(SS4-SS6)
 
 
 
 
 
 
 
Scheme-10: General synthetic route for 2-azetidinone and 4-thiazolidinone 
derivatives 
Code   R 
SB1,SS1,SS4 N(CH3)2 
SB2,SS2,SS5 NO2 
SB3,SS3,SS6 OH 
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R NH2+ O
R
2
R
1
R N
R
1
R
2
+ H2O
R N
+
R
1
R
2
H
carbonyl grp
schiff base  
Scheme-11: Mechanism for formation of Schiff base 
N
H
Ar
-
Ph
HCl
O Cl
H
N
+
H
Ar
-
Ph
H
Cl
H
O
Et3N :B
N
Ph O
HClAr
-
 
Scheme-12: Mechanism for formation of azetidinone 
Both the ketene and the imine are molecules that can act as either nucleophiles or 
electrophiles. In the first step, the imine adds to the ketene as a nucleophile. The 
subsequent cycloaddition delivers the azetidin-2-one. (Verma M. et al., 1974) 
          
R1 N
R
3
R
2 +
O
OHSH
R
1
NH
S
O
OH
R
3
R
2
S
N
R
1
R2
R
3
O
schiff base mercapto acetic acid
Thiazolidinone 
 Scheme-13: Mechanism for formation of thiazolidinone 
The nucleophilic attack of the mercapto acetic acid anion on carbon of azomethine 
(Schiff base) forms an uncyclized intermediate. The subsequent cycloaddition delivers 
the thiazolidin-4-one. (Verma M. et al., 1974) 
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6.2 Interpretation of spectral data of synthesized compounds 
6.2.1 Spectral analysis of 4-[4-(dimethylaminobenzylidene)amino]benzoic acid (SB1) 
UV: (Fig-39) 
λmax (MeOH)                              341.0 (ε max 0.3896) 
λmax (MeOH)                              267.0 (ε max 0.9121) 
 
IR (KBr): (Fig-40) 
Wavelength (cm-1)  Assignment  
2917.19  Aromatic C-H (stretching) 
1679.83  C=N (stretching) 
1585.05  Aromatic C=C (stretching) 
1417.45  C-O-H (bending) 
1434.40 N-CH3 (stretching) 
1286.58  C-O (stretching) 
819.47  Aromatic C-H (bending) 
 
NMR (DMSO-d6): (Fig- 41&42) 
                            
O
OH
N
N
8.17.5
7.5 8.1 10.17
8.60
7.426.81
6.81 7.42
3.02
3.02
  
(8 aromatic protons, 6 methyl protons, 1 proton on Schiff base and 1 proton on carboxylic acid) 
Δ Assignment 
10.17 (1H, s, Ar-COOH) 
8.60 (1H, s, CH=N) 
8.1-7.50 (4H, m, Ar-H of  benzoic acid ) 
7.42-6.81 (4H, m, Ar-H of dimethylamino phenyl group) 
3.02 (6H, s, N(CH3)2) 
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       Fig-  39 : UV Spectrum of compound SB1 
46 
  
 
Fig- 40: IR Spectrum of compound SB1 
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 Fig- 41:1H-NMR Spectrum of the compound SB1 
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Fig- 42:1H-NMR Spectrum of the compound SB1(Zoom View) 
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6.2.2 Spectral analysis of 4-[4-(nitrobenzylidene) amino] benzoic acid (SB2) 
UV: (Fig-43) 
λmax (MeOH)                              275.0 (ε max 1.0647) 
 
IR (KBr): (Fig-44 ) 
Wavelength (cm-1)  Assignment  
3074.08 Aromatic C-H (stretching) 
1681.92 C=N (stretching) 
1589.52 Aromatic C=C (stretching) 
1516.59 Aromatic NO2 asymmentric (stretching) 
1427.20 C-O-H (bending) 
1343.43 Aromatic NO2 symmentric (stretching) 
1295.32 C-O (stretching) 
832.22 Aromatic C-H (bending) 
 
NMR (DMSO-d6): (Fig-45&46 ) 
                         
O
OH
N
N+
O
-O
8.177.4
7.4 8.17 10.17
8.60
8.158.33
8.33 8.15
 
(8 aromatic protons, 1 proton on Schiff base and 1 proton on carboxylic acid) 
 
δ Assignment 
10.17 (1H, s, Ar-COOH) 
8.60 (1H, s, CH=N) 
8.1-7.4 (8H, m, Ar-H) 
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Fig-43 : UV Spectrum of compound SB2
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Fig- 44: IR Spectrum of compound SB2 
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                                  Fig- 45:1H-NMR Spectrum of the compound SB2 
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Fig- 46:1H-NMR Spectrum of the compound of SB2
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6.2.3 Spectral analysis of 4-[4-(hydroxybenzylidene) amino]benzoic acid (SB3) 
UV: (Fig- 47) 
λmax (MeOH)                              284.5 (ε max 1.1012) 
 
λmax (MeOH)                              220.0 (ε max 0.7090) 
 
IR (KBr): (Fig-48) 
Wavelength (cm-1)  Assignment  
3240.51 O-H (stretching) 
2885.78  Aromatic C-H (stretching) 
1685.99  C=N (stretching) 
1575.44  Aromatic C=C (stretching) 
1421.83  C-O-H (bending) 
1285.44  C-O (stretching) 
835.16  Aromatic C-H (bending) 
 
NMR (DMSO-d6): (Fig-49-50) 
                         
O
OH
N
HO
8.17.65
7.65 8.1 10.17
8.52
7.426.84
6.84 7.42
9.6
 
(8 aromatic protons, 1 hydroxy proton, 1 proton on Schiff base and 1 proton on 
carboxylic acid) 
δ Assignment  
10.65 (1H, s, Ar-COOH) 
9.68 (1H, s, Ar-OH) 
8.52 (1H, s, CH=N) 
8.17-7.65 (4H, m, Ar-H of benzoic acid) 
7.42-6.84 (4H, m, Ar-H of hydroxyl phenyl group) 
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Fig-47 : UV Spectrum of compound SB3
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Fig- 48: IR Spectrum of compound SB3  
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Fig- 49:1H-NMR Spectrum of the compound SB3 
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Fig- 50:1H-NMR Spectrum of the compound SB3 
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Fig- 51:1H-NMR Spectrum of the compound SB3
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6.2.4 Spectral analysis of 4-[3-chloro-2-[4-dimethylaminophenyl]-4-oxoazetidin-1-
yl]benzoic acid (SS1) 
UV: (Fig- 52) 
λmax (MeOH)                              339.5 (ε max 1.4282) 
 
λmax (MeOH)                              285.5 (ε max 1.0659) 
 
IR (KBr): (Fig- 53) 
Wavelength (cm-1)  Assignment  
2916.76  Aromatic C-H (stretching) 
1659.04  C=O azetidinone(stretching) 
1600.46  Aromatic C=C (stretching) 
1436.72  C-O-H (bending) 
1366.95  C-N (stretching) 
1436.72 N-CH3 (stretching) 
1285.86  C-O (stretching) 
856.09  Aromatic C-H (bending) 
773.83  C-Cl (stretching) 
 
NMR (DMSO-d6): (Fig-54-56) 
                         O
OH
N
O
N
Cl
8.01
7.74
7.74
8.01
10.17
4.65
5.50
7.16
6.60
6.60
7.16
2.91
2.91
 
(8 aromatic protons, 6 methyl protons, 2 cyclic protons and 1 proton on carboxylic 
acid) 
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δ        Assignment 
10.17 (1H, s, Ar-COOH) 
8.01-7.74 (4H, m, Ar-H of benzoic acid) 
7.16-6.60 (4H, m, Ar-H of dimethyl amino phenyl) 
5.50 (1H. d, CH-Cl) 
4.65 (1H. d, CH) 
2.91 (6H, s, N(CH3)2) 
 
MASS: (Fig-57) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
 
N
COOH
ClO
N
CH3
CH3
e-
N
COOH
ClO
N
+
CH3
CH3
m/z 344 m/z 344 (M
+
 peak)  
 
 
N
COOH
ClO
N
+
CH3
CH3
m/z 344 (M
+
 peak)
Cl
N
CH
+
COOH
O
N
CH3
CH3
m/z 309
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N
CH
+
COOH
O
N
CH3
CH3
m/z 309
N
CH3
CH3
N
CH
+
COOH
O m/z 266
N
CH
+
COOH
O
m/z 254 (base peak)
N
CH
+
O
C=O
m/z 237
C
+
COOH
m/z 121
C
+
HOOC
m/z 95
 
Fig- 58: Fragmentation of 4-[3-chloro-2-[4-dimethylaminophenyl]-4-oxoazetidin-
1-yl] benzoic acid 
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     Fig-52: UV Spectrum of compound SS1 
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Fig-53: IR Spectrum of compound SS1 
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     Fig-54: 1H-NMR Spectrum of the compound SS1 
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Fig-55: 1H-NMR Spectrum of the compound SS1 (Zoom View 1) 
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Fig-56: 1H-NMR Spectrum of the compound SS1 (Zoom View 2) 
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Fig-57: Mass Spectrum of the compound SS1
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6.2.2 Spectral analysis of 4-[3-chloro-2-(4-nitrophenyl)-4-oxoazetidin-1-yl]- 
benzoic acid (SS2) 
UV: (Fig-59) 
λmax (MeOH)                              175.5 (ε max 1.5068) 
IR (KBr): (Fig-60) 
Wavelength (cm-1)  Assignment  
3074.16 Aromatic C-H (stretching) 
1682.41 C=O azetidinone(stretching) 
1600.74 Aromatic C=C (stretching) 
1517.57 Aromatic NO2 asymmetric (stretching) 
1426.40 C-O-H (bending) 
1344.94 Aromatic NO2 symmetric (stretching) 
1317.05 C-N (stretching)  
1294.66 C-O (stretching) 
857.10 Aromatic C-H (bending) 
775.27 C-Cl (stretching) 
 
NMR (DMSO-d6): (Fig-61-63) 
                                   O
OH
N
O
N+
O
-O
Cl
8.18
7.30
7.30
8.18
10.17
4.76
5.03
7.76
8.06
8.06
7.76
 
            (8 aromatic protons, 2 cyclic protons and 1 proton on carboxylic acid) 
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δ        Assignment 
10.17 (1H, s, Ar-COOH) 
8.06-7.30 (8H, m, Ar-H) 
5.03 (1H. d, CH-Cl) 
 4.76 (1H. d, CH) 
 
MASS: (Fig-64) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
 
N
COOH
ClO
NO2
e-
N
COOH
ClO
NO2
m/z 346 m/z 346 (M
+
 peak)
N
COOH
ClO
NO2
m/z 346 
Cl
N
CH
+
COOH
O
NO2
m/z 312
C+
COOH
m/z 121
C+
HOOC
m/z 95
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m/z 311
N
CH+
COOH
O
N+
O-
O
m/z 311
N
CH+
COOH
O
O
m/z 282
NO
N
C
+
COOH
O H
N
CH+
COOH
O
NO2
m/z 254 (base peak)
N
CH+
C
+
O
m/z 209
 
 
 
Fig-65: Fragmentation of 4-[3-chloro-2-(4-nitrophenyl)-4-oxoazetidin-1-
yl]benzoic acid   
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Fig-59: UV Spectrum of compound SS2 
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Fig-60: IR Spectrum of compound SS2 
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     Fig-61: 1H-NMR Spectrum of the compound SS2 
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Fig-62: 1H-NMR Spectrum of the compound SS2(Zoom View 1) 
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Fig-63: 1H-NMR Spectrum of the compound SS2(Zoom View 3) 
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Fig-64: Mass Spectrum of the compound SS2 
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6.2.3. Spectral analysis of 4-[3-chloro-2-(4-hydroxyphenyl)-4-oxoazetidin-1-yl]- 
benzoic acid (SS3) 
UV: (Fig-66) 
λmax (MeOH)                              282.0 (ε max 2.6021) 
IR (KBr): (Fig-67) 
Wavelength (cm-1)  Assignment  
3247.31 OH (stretching ) 
2966.56 Aromatic C-H (stretching) 
1685.31 C=O azetidinone(stretching) 
1593.82 Aromatic C=C (stretching) 
1421.60 C-O-H (bending) 
1313.51 C-N (stretching)  
1285.27 C-O (stretching) 
857.10 Aromatic C-H (bending) 
775.27 C-Cl (stretching) 
 
NMR (DMSO-d6): (Fig-68 & 69) 
                                   O
OH
N
O
HO
Cl
8.01
7.23
7.23
8.01
10.22
4.58
5.43
6.91
6.64
6.64
6.91
9.57
 
 (8 aromatic protons, 2 cyclic protons, 1 hydroxy proton and 1 proton on carboxylic 
acid) 
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δ        Assignment 
10.22 (1H, s, Ar-COOH) 
9.57 (1H, s, Ar-OH) 
8.01-7.23 (4H, m, Ar-H of benzoic acid) 
6.91-6.64 (4H, m, Ar-H of hydroxyl group) 
5.43 (1H. d, CH-Cl) 
4.58 (1H. d, CH) 
 
MASS: (Fig-70) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
 
N
COOH
ClO
OH
e-
N
COOH
ClO
OH+
m/z 317 (M
+
 peak)
m/z 317
N
COOH
ClO
OH
+
m/z 317
Cl
N
CH
+
COOH
O
OH
+
m/z 282
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N
CH
+
COOH
O
OH
+
m/z 282 m/z 266
N
CH
+
COOH
O
C
+
COOH
m/z 121
C
+
HOOC
m/z 95
N
C
+
COOH
O H
m/z 254
N
COOH
ClO
OH
+
m/z 317
CO
N
COOH
Cl
OH
+
m/z 298
m/z 261
N
COOH
Cl
N
C
+
C
+
O H
m/z 209
 
 
Fig-71: Fragmentation of 4-[3-chloro-2-(4-hydroxyphenyl)-4-oxoazetidin-1-yl] 
benzoic acid  
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Fig-66: UV Spectrum of compound SS3 
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Fig-67: IR Spectrum of compound SS3 
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Fig-68: 1H-NMR Spectrum of the compound SS3 
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Fig-69: 1H-NMR Spectrum of the compound SS3(Zoom View 1) 
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Fig-70: Mass Spectrum of the compound SS3
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6.2.4. Spectral analysis of 4-[2-[4-dimethylaminophenyl]-4-oxo-1,3-thiazolidin-3-yl]- 
benzoic acid (SS4) 
UV: (Fig-72) 
λmax (MeOH)                              340.0 (ε max 0.9750) 
λmax (MeOH)                              270.5 (ε max 1.0425) 
IR (KBr): (Fig-73) 
Wavelength (cm-1)  Assignment  
2923.84 Aromatic C-H (stretching) 
1658.42 C=O (stretching) 
1600.58 Aromatic C=C (stretching) 
1456.70 N-CH3 (stretching) 
1437.31 C-O-H (bending) 
1362.63 C-N (stretching)  
1252.41 C-O (stretching) 
820.93 Aromatic C-H (bending) 
691.78 C-S (stretching) 
 
NMR (DMSO-d6): (Fig-74-76) 
                                 
OHO
S
N
O
N
7.95
7.717.71
7.95
10.17
7.30
4.76
6.62
6.73
6.73
6.62
2.91
2.91
 
(8 aromatic protons, 6 methyl protons, 3 cyclic protons and 1 proton on carboxylic 
acid) 
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δ        Assignment 
10.17 (1H, s, Ar-COOH) 
7.95-7.71 (4H, m, Ar-H of benzoic acid) 
4.76 (2H, s, CH2-S) 
6.73-6.62 (4H, m, Ar-H of dimethyl amino phenyl group) 
7.30 (1H. s, S-CH-N) 
2.91 (6H, s, N(CH3)2) 
 
MASS: (Fig-77) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
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N
S
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COOH
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N
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+
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Fig-78: Fragmentation of 4-[2-[4-dimethylaminophenyl]-4-oxo-1,3-thiazolidin-3-
yl]benzoic acid 
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Fig-72: UV Spectrum of compound SS4 
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Fig-73: IR Spectrum of compound SS4 
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Fig-74: 1H-NMR Spectrum of the compound SS4 
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Fig-75: 1H-NMR Spectrum of the compound SS4(Zoom View 1) 
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Fig-76: 1H-NMR Spectrum of the compound SS4(Zoom View 2) 
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Fig-77: Mass Spectrum of the compound SS4 
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6.2.5. Spectral analysis of 4-{2-[4-nitrophenyl]-4-oxo-1,3-thiazolidin-3-yl}- 
benzoic acid (SS5) 
UV: (Fig-79) 
λmax (MeOH)                              290.0 (ε max 0.9673) 
IR (KBr): (Fig-80) 
Wavelength (cm-1)  Assignment  
3106.97 Aromatic C-H (stretching) 
1679.56 C=O (stretching) 
1597.47 Aromatic C=C (stretching) 
1517.93 Aromatic NO2 asymmetric (stretching) 
1408.50 C-O-H (bending) 
1347.18 C-N (stretching)  
1316.19 Aromatic NO2 symmetric (stretching) 
1247.15 C-O (stretching) 
854.70 Aromatic C-H (bending) 
698.33 C-S (stretching) 
 
NMR (DMSO-d6): (Fig-81 & 82) 
                                  
OHO
S
N
O
N+
O
-O
8.11
7.147.14
8.11
10.22
7.37
4.52
7.07
7.66
7.66
7.07
 
            (8 aromatic protons, 3 cyclic protons and 1 proton on carboxylic acid) 
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δ  Assignment 
10.22 (1H, s, Ar-COOH) 
  8.11-7.66 (8H, m, Ar-H) 
7.37 (1H. s, S-CH-N) 
4.52 (2H, s, CH2-S) 
 
MASS: (Fig-83) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
COOH
N
S
O
NO 2
m/z 344
e-
COOH
N
S
O
NO 2
m/z 344 (M
+
 peak)
+
 
N
S
O
C
+
COOH
m/z 299
COOH
N
S
O
NO 2
m/z 344
C
+
N
S
O
C
+
m/z 253
 
COOH
N
S
O
O+
COOH
N
S
O
NO2
NO
COOH
N
S
O
CH2
CH3
m/z 287
m/z 316m/z 287
COOH
N
CH+
S
O
m/z 222  
Fig-84: Fragmentation of 4-{2-[4-nitrophenyl]-4-oxo-1,3-thiazolidin-3-yl} benzoic acid 
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Fig-79: UV Spectrum of compound SS5
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Fig-80: IR Spectrum of compound SS5 
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Fig-81: 1H-NMR Spectrum of the compound SS5 
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Fig-82: 1H-NMR Spectrum of the compound SS5(Zoom View 1) 
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Fig-83: Mass Spectrum of the compound SS5    
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6.2.6. Spectral analysis of 4-{2-[4-hydroxyphenyl]-4-oxo-1,3-thiazolidin-3-yl}- 
benzoic acid (SS6) 
UV: (Fig-85) 
λmax (MeOH)                              264.5 (ε max 1.6844) 
IR (KBr): (Fig-86) 
Wavelength (cm-1)  Assignment  
3309.29 OH (stretching) 
2922.65 Aromatic C-H (stretching) 
1686.48 C=O (stretching) 
1593.80 Aromatic C=C (stretching) 
1421.46 C-O-H (bending) 
1315.45 C-N (stretching)  
1282.92  OH (bending) 
1254.86 C-O (stretching) 
836.03 Aromatic C-H (bending) 
691.88 C-S (stretching) 
 
NMR (DMSO-d6): (Fig-87-89) 
                               
OHO
S
N
O
HO
8.01
7.157.15
8.01
10.22
7.22
4.76
6.91
6.59
6.59
6.919.78
 
(8 aromatic protons, 3 cyclic protons, one hydroxyl proton and                                       
one proton on  carboxylic acid) 
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δ        Assignment 
10.22 (1H, s, Ar-COOH) 
9.78  (1H, s, Ar-OH) 
8.01-7.15 (4H, m, Ar-H of benzoic acid) 
7.22 (1H. s, S-CH-N) 
6.91-6.59 (4H, m, Ar-H of hydroxyl phenyl group) 
4.76 (2H, s, CH2-S) 
 
MASS: (Fig-90) 
The structure of the compound was further confirmed by its fragmentation peaks 
which are as follows: 
COOH
N
SO
OH
e-
COOH
N
SO
OH
+
m/z 315 m/z 315 (M
+
 peak)  
COOH
N
SO
OH
+ N
SO
OH
m/z 315
m/z 194
CH CH
C
+
COOH
m/z 95
C
+
COOH
m/z 121
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Fig-91: Fragmentation of 4-{2-[4-hydroxyphenyl]-4-oxo-1,3-thiazolidin-3-
yl}benzoic acid 
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     Fig-85: UV Spectrum of compound SS6 
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Fig-86: IR Spectrum of compound SS6 
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Fig-87: 1H-NMR Spectrum of the compound SS6 
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Fig-88: 1H-NMR Spectrum of the compound SS6(Zoom View 1) 
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Fig-89: 1H-NMR Spectrum of the compound SS6(Zoom View 2) 
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Fig-90: Mass Spectrum of the compound SS6
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6.3- Table 1: Physical and Analytical Data of the Synthesized Compounds 
Code    
No. 
 
Name  Nature Solubility  Molecular       
Weight (g) 
Molecular 
Formula 
Melting 
Point 
(°C) 
Percentage 
Yield 
(%) 
Rf  Values 
(C6H5: 
C3H6O)9:1 
SB1 
 
4-(4-dimethylamino 
benzylideneamino)b
enzoic acid 
 
Reddish 
brown 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol. 
Insoluble :Water 
268.31 
 
C16H16N2O2     201 
  
80.37 0.71 
SB2 
 
4-(4-
nitrobenzylideneami
no)benzoic acid 
 
Yellowish 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol. 
Insoluble :Water 
270.24 C14H10N2O4     262 
 
75.24 0.67 
SB3 
 
4-(4-
hydroxybenzylidene
amino)benzoic acid 
 
Light yellow 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol.  
Insoluble :Water 
241.24 C14H11NO3     215 
 
 
73.72 0.45 
111 
 
SS1 
 
4-{3-chloro-2-[4-
(dimethylamino)phe
nyl]-4-oxoazetidin-
1-yl}benzoic acid 
 
Reddish 
brown 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform. 
Insoluble :Water 
344.79 C18H17O3N2Cl     182 
 
65.37 0.71 
SS2 
 
4-[3-chloro-2-(4-
nitrophenyl)-4-
oxoazetidin-1-
yl]benzoic acid 
 
Yellowish 
amorphous 
powder. 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform. 
Insoluble :Water 
346.72 C16H11O5N2Cl     227 
 
  72.34  0.51 
SS3 
 
4-[3-chloro-2-(4-
hydroxyphenyl)-4-
oxoazetidin-1 
yl]benzoic acid 
 
Light yellow 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide.   
 Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform. 
Insoluble :Water 
 
317.72 C16H12O4NCl 197 
 
 
  70.11 0.66 
SS4 
 
4-{2-[4-
(dimethylamino)phe
nyl]-4-oxo-1,3-
Reddish 
brown 
amorphous 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
342.41 C18H18N2O3S 172   69.60 0.47 
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thiazolidin-3-
yl}benzoic acid 
 
powder Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform 
Insoluble :Water 
SS5 4-[2-(4-
nitrophenyl)-4-oxo-
1,3-thiazolidin-3-
yl]benzoic acid 
 
Yellowish 
amorphous 
powder. 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform. 
Insoluble :Water 
344.34 C16H12N2O5S 298 
 
 
  75.98 0.62 
SS6 
 
4-[2-(4-
hydroxyphenyl)-4-
oxo-1,3-thiazolidin-
3-yl]benzoic acid 
 
Light yellow 
amorphous 
powder 
Soluble: Methanol, ethanol, 
dimethyl formamide. 
Slightly soluble: Benzene, 
isopropyl alcohol, 
chloroform. 
Insoluble :Water 
314.34 
 
C16H13O4NS 248  63.21 0.53 
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6.4. Screening of antimicrobial activity 
         The synthesized compounds SS1-SS6, were evaluated for their antimicrobial 
activity by disc diffusion method. As per the data obtained, it was confirmed that all 
the tested compounds possess antibacterial and antifungal activity against the tested 
bacterial and fungal strains. 
 The synthesized compound SS1 showed the significant activity in the following 
order: Staphylococcus aureus > Escherichia coli > Candida albicans. 
 The synthesized compound SS2 showed the significant activity in the following 
order: Staphylococcus aureus > Candida albicans>Escherichia coli. 
 The synthesized compound SS3 showed the significant activity in the following 
order: Escherichia coli > Candida albicans >Staphylococcus aureus. 
 The synthesized compound SS4 showed the significant activity in the following 
order: Candida albicans> Escherichia coli> Staphylococcus aureus. 
 The synthesized compound SS5 showed the significant activity in the following 
order: Candida albicans> Escherichia coli= Staphylococcus aureus. 
 The synthesized compound SS6 showed the significant activity in the following 
order: Candida albicans> Escherichia coli> Staphylococcus aureus. 
        The above observations showed that 2-azetidinone derivatives are found to be 
more active in inhibiting the bacterial strains and 4-thiazolidinonones were more 
active against fungal strains. 
          However, the antimicrobial activity of the synthesized compounds against the 
tested organisms was found to be less than that of the standard antibacterial drug 
Ciprofloxacin and standard antifungal drug Ketoconazole at their tested dose level.
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Table 2: In vitro antimicrobial activity of synthesized compounds by Disc diffusion method 
 
 
 
   
                       
 
 
 
 
 
 
 
 
                         Std* - Ciprofloxacin (100 µg /disc) 
                         Std** - Ketaconazole (100 µg /disc)
 
S.No 
 
 
Compound 
Diameter of zone of inhibition (in mm) 
Staphylococcus aureus Escherichia coli Candida albicans 
25 μg 100 μg Std* 25 μg 100 μg Std* 25 μg 100 μg Std** 
1. SS1 18 29.5 32 14 18 29 11 
 
17 30 
2. SS2 17 28 32 11 13.5 29 14 
 
18 30 
3. SS3 12 18.6 32 22 27 29 19 
 
22 30 
4. SS4 10 14 32 11 14.5 29 21 
 
25.4 30 
5. SS5 11 17 32 12 17 29 23 
 
27 30 
6. SS6 14 19 32 15 21 29 16 24.3 30 
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    Fig-92:  Antibacterial activity of compound SS1 against Staphylococcus aureus       
 
 
               Fig-93: Antibacterial activity of compound SS3 against Escherichia coli 
  
 
                 Fig-94: Antifungal activity of compound SS5 against Candida albicans 
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6.4.a. Acute oral toxicity 
The acute toxicity of the synthesized compounds, SS5 & SS6 was determined 
by using swiss albino mice (20-25 g). The animals were fasted for 24 h prior to the 
experiment and acute class toxic (OECD 423) method of CPCSEA was adapted for 
acute toxicity studies. The animals were treated up to the dose level of 300 mg and 
since no mortality was observed up to that level, 1/6th of the lethal dose (50 mg/ kg 
b.w) was taken as effective dose ED50(Therapeutic dose). 
6.5. Anti-inflammatory activity 
The synthesized derivatives, SS5 & SS6 were selected for the screening of anti-
inflammatory activity using carrageenan induced paw edema method. The test 
compounds exhibited significant activity in acute inflammatory models in rats after 1 
h, 2 h and 3 h. The results were tabulated in Table-3. 
 The SS5 showed significant activity at 1 h, 2 h and 3 h and the mean paw 
edema volume at these hours were 0.60 ± 0.057, 0.70 ± 0.057 and 0.81 ± 
0.066 respectively. The compound was found to have statistically significant 
activity at 1st h, 2nd h but it was highly significant in 3rd h.  
 The SS6 showed significant activity at 1 h, 2 h and 3 h and the mean paw 
edema volume at these hours were 0.56 ± 0.066, 0.66 ± 0.066 and 0.73 ± 
0.066 respectively. The compound showed highly significant activity at 3 h, 
statistically significant at 1 h and 2 h. 
 The standard drug diclofenac sodium was significant at 1 h, 2 h and 3 h and 
the activity at these hours were 0.46 ± 0.066, 0.53 ± 0.088 and 0.53 ± 0.088 
respectively, but it was highly significant at 3 h. 
Carrageenan-induced hind paw edema was the standard experimental model of 
acute inflammation. The edema induced by carrageenan injection involves three 
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phases of chemical mediator release in an orderly sequence (Guang-Qin. et al., 2008). 
The first phase (1 h) involves the release of histamine and serotonin and is 
characterized by increase in vascular permeability. The second phase (2 h) is 
mediated by release of bradykinin, an important chemical mediator of both pain and 
inflammation. Release of prostaglandins and cyclooxygenases products takes place in 
the third and final phase (3 h) (Prakash. et al., 2009). 
The compounds produced a significant inhibition of carrageenan induced paw 
edema at all the three phases. Therefore, it can be inferred that the highly significant 
inhibitory effect of test compounds on carrageenan induced inflammation could be 
due to inhibition of the enzyme cyclooxygenase and subsequent inhibition of 
prostaglandin synthesis. Significant inhibition of paw edema in the early hours of 
study by compounds could be attributed to the inhibition of histamine and/or 
serotonin. 
The compounds SS5 & SS6 exhibited maximum inhibition of 42.31 % and 47.32 
% respectively where as the diclofenac sodium showed percentage reduction in edema 
volume by 62.14 %.  From the data it was found that the test compound SS6 showed 
superior activity in the inhibition of edema than SS5. However, both the tested 
compounds showed less activity than the standard drug.
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Table 3: Anti-inflammatory activity by carrageenan induced paw edema model 
 
Group Dose  
(mg /kg) 
            Paw edema volume (in ml) at (mean ± SEM) 
 
    
0 hr 1 hr 2 hr 3 hr 
Control  - 0.33 ± 0.066 
 
0.9 ± 0.088 
 
1.1 ± 0.088 
 
1.47 ± 0.057 
 
Diclofenac sodium 20 0.23 ± 0.033 
       
0.46 ± 0.066** 
(48.88) 
0.53 ± 0.088** 
(51.51) 
0.55 ± 0.088*** 
(62.14) 
SS5 50 0.37 ± 0.057 0.60 ± 0.057* 
(33.31) 
0.70 ± 0.057* 
(36.32) 
0.81 ± 0.066*** 
(42.31) 
SS6 50 0.31 ± 0.066 
 
0.56 ± 0.066* 
(37.71) 
0.66 ± 0.066** 
(40.01) 
0.73 ± 0.066*** 
(47.32) 
 
                 n = 3 in each group.*p< 0.05, **p < 0.01 and ***p<0.001 when compared to control (One-way ANOVA followed by    
                Bonferroni test)                     
                 Figures in the parenthesis indicate % inhibition of paw edema 
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6.6. Analgesic activity 
The synthesized derivatives, SS5 & SS6 were selected for the screening of analgesic 
activity using Eddy's hot plate method. The results were shown in Table-4. The 
compounds showed significant (p<0.001, p<0.01) analgesic activity at 60, 90 and 180 
min.  
 The compound SS5, showed significant activity at 90 and 180 min and the latency 
time was found to be 12.29 ± 0.066 and 11.36 ± 0.577 respectively.  
 The compound SS6, showed significant activity at 60, 90 and 180 min and the 
latency time was found to be 12.13 ± 1.157, 13.14 ± 0.882 and 11.79 ± 0.066 
respectively, but the compound showed highly significant activity at 90 min. 
 The standard drug pentazocaine was found to have significant increase in latency 
time 12.87 ± 0.577, 12.91 ± 0.577, 13.65 ± 0.882 and 11.83 ± 1.1 respectively at 30, 
60, 90 and 180 min respectively, but the compounds showed highly significant 
activity at 90 min. 
The hot plate test measures the complex response to a non-inflammatory, acute 
nociceptive input and is one of the models normally used for studying central 
nociceptive activity. It is an established fact that any agent that causes prolongation of 
the hot plate latency using this test must be acting centrally. Prolongation of the reaction 
time in hot plate test signifies that the compounds act through central mechanism. 
(Zakaria. et al., 2008) 
In both test compounds and standard, the percentage analgesia was found to be 
maximum at 90 min and decreased at 180 min. From these data it was found that the 
test compound SS6 (56.80 %) showed superior activity than SS5 (51.54 %). However, 
both the test compounds were found to less activity than the standard drug, pentazocine 
(60.02 %).  
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Table 4: Analgesic activity by Eddy’s hot plate method 
 
 
 
 
 
 
 
 
 
 
 
 
n = 3 in each group *p< 0.01 and **p<0.001 when compared to control (One-way ANOVA followed by Bonferroni test)                  
                          Figures in the parenthesis indicate % paw licking/jump response
Group  Dose  
(mg /kg) 
                          Reaction time ( mean±SEM, sec) at 
0 min 30 min 60 min 90 min 180 min 
Control  - 7.91 ± 0.577 7.94 ± 0.577 8.01 ± 0.577 8.17 ± 0.577 8.20 ± 0.577 
Pentazocine   20 8.53 ± 1.157 12.87 ± 0.577* 
(50.87) 
12.91± 0.577* 
(51.34) 
13.65 ± 0.882** 
(60.02) 
11.83 ± 1.1* 
(38.68) 
SS5 50 8.11 ± 1.157 11.24 ± 1.157 
(38.59) 
11.47 ± 1.157 
(41.4) 
12.29 ± 0.066** 
(51.54) 
11.36 ± 0.577* 
(40.07) 
SS6 50 8.38 ± 0.066 11.65 ± 1.157 
(39.02) 
12.13 ± 0.066* 
(44.74) 
13.14 ± 0.882** 
(56.80) 
11.79 ± 0.066* 
(40.69) 
  
 
 
 
 SUMMARY 
& 
CONCLUSION 
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7. SUMMARY AND CONCLUSION 
         The development of drug resistance has limited the successful application of 
many antibiotics and therefore this phenomenon has given consequences to health. 
The design of potential reversers of microbial resistance has thus become a desirable 
goal in the field of medicinal chemistry. Moreover azetidinone and thiazolidinone are 
the pharmacophore of various molecules which occupies prominent places in the field 
of antimicrobial agents, the importance of which are documented in literature. 
          In the present study, the appropriate aldehydes were reacted with p-amino 
benzoic acid to give the corresponding a Schiff bases (SB1-SB3) which undergoes 
reaction with chloroacetyl chloride in presence of tri ethylamine results in the 
formation of corresponding  2-azetidinone derivatives (SS1-SS3) by Staudinger 
reaction. Similarly, the Schiff bases (SB1-SB3) reacted with mercaptoacetic acid to 
give 4-thiazolidinone derivatives (SS4-SS6). Both 2-azetidinones and 4-
thiazolidinones resulted in good to excellent yield. The purity of the synthesized 
compounds was checked by appearance of single spot in thin layer chromatography 
(Rf) and determining melting point. 
        The structure of the synthesized compounds were established by spectral (IR, 1H 
NMR and Mass) analysis data. The N=C band (1679-1685 cm-1) and N=CH proton 
signal (δ 8.52-8.60) in IR and NMR spectrum respectively in the synthesized 
compounds (SB1-SB3), confirmed the formation of Schiff base nucleus. The C=O 
stretching band (1247-1295 cm-1), C-O-H bending vibration (1408-1437 cm-1) in IR 
spectrum and a singlet for 1 proton at δ 10.17-10.65 and multiplet for 4 protons at δ 
7.15-8.17 in 1H NMR, indicated the presence of benzoic acid group in all the 
synthesized compounds.  
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          The C=O band (1659-1685 cm-1), CH-Cl band (773-775 cm-1)  in IR spectrum 
and the N-CH proton signal (δ 4.58-4.76) and CH-Cl (δ 5.03-5.50) in 1H NMR 
spectrum in the synthesized compounds (SS1-SS3), confirmed the formation of 3-
chloro-2-azetidinone nucleus. The C=O band (1658-1686 cm-1) and C-S-C band (691-
698 cm-1) in IR spectrum and N-CH proton signal (δ 4.52- 4.76) and CH2-S (δ 7.22-
7.36) in 1H NMR spectrum in the synthesized compounds (SS4-SS6) confirmed the 
formation of 4-thiazolidinone nucleus. 
            In SB1, SS1 & SS4, showed a singlet for 6 protons at δ 2.91-3.02. and a 
multiplet for 4 protons at δ 6.60-7.42 in 1H NMR spectrum and a band at 1434-1456 
cm-1 for N-(CH3)2 in IR spectrum, confirmed the substitution of dimethylamino 
phenyl group.  
           In SB2, SS2 & SS5, presence of  strong bands at 1517 cm-1 and 1316-1344 cm-1 
corresponding to the asymmetric and symmetric O=N=O stretching in IR spectrum 
and a multiplet for 4 protons at δ 7.07-8.33 in 1H NMR,  indicated the presence of 
nitrophenyl group.  
           In SB3, SS3 & SS6, the 1H NMR showed a singlet for 1 proton at δ 9.57-9.78 
and muliplet for 4 protons at δ 6.59-7.42, whereas the IR spectrum of these 
compounds showed band at 3240-3309 cm-1  for OH stretching , indicated the 
presences of hydroxy phenyl group. 
         The mass spectrum of the synthesized compounds produced (M+) Molecular 
ion peaks such as 344.79, 346.72, 317.72, 342.41, 344.34 and 314.34 for SS1, SS2, 
SS3, SS4, SS5 and SS6 respectively corresponds to their molecular formulas. The 
predicted chemical structure of titled compounds was further supported by the 
fragmentation peaks.  
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          Most the synthesized compounds exhibited good activity against the studied 
set of microorganisms. All the compounds showed good anti bacterial and antifungal 
activity even at less concentration. The SS1, 4-[3-chloro-2-[4-dimethylaminophenyl]-
4-oxoazetidin-1-yl] benzoic acid was found to be more active against Staphylococcus 
aureus (gram +ve bacteria). The SS3, 4-[3-chloro-2-(4-hydroxyphenyl)-4-
oxoazetidin-1-yl] benzoic acid was found to be more potent active against 
Escherichia coli (gram –ve bacteria). The SS5, 4-{2-[4-nitrophenyl]-4-oxo-1, 3-
thiazolidin-3-yl} benzoic acid was found to be active against Candida albicans. 
From the data, it is evident that the 2-azetidinones was more active against the 
bacterial strains and 4-thiazolidinones were more active against the fungal strains. 
         The synthesized compounds SS5 & SS6 were screened for the anti-inflammatory 
by carrageenan induced paw edema method and the percentage reduction in the paw 
edema was measured using plethysmograph. The synthesized compounds are found to 
be highly significant (p<0.001) at 3 h. The compounds SS5 & SS6 exhibited maximum 
inhibition of 42.31 % and 47.32 % respectively where as the standard diclofenac 
sodium showed reduction in edema volume by 62.14 %. 
         The analgesic activities of both the synthesized compounds were screened by 
Eddy’s hot plate method. The activity was studied at 50 mg/kg b.w. and their effects 
were measured at time intervals of 30, 60, 90, and 180 minutes. The synthesized 
compounds showed significant analgesic activity (p<0.001) at 90 min. The maximum 
analgesic activity and the percentage analgesia of SS5 & SS6 was found to be 51.54 % 
and 56.80 % respectively whereas 60.02 % analgesia was exhibited by the standard 
drug.   
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        However, in both evaluations, the compounds SS6, 4-[2-(4-hydroxyphenyl)-4-
oxo-1, 3-thiazolidin-3-yl] benzoic acid showed better activity than SS5. This may be 
due to the presence of electron donating group such as hydroxy group at the 2nd 
position of 4-thiazolidinone than the electron withdrawing group NO2 group at SS5.          
         The synthesized compounds have exhibited significant biological activities; 
their efficacy is not enough to develop them into clinically useful agents. However 
these compounds need special attention because of their marked activity. Therefore, 
the further modification of these compounds is quiet desirable and since acute anti-
inflammatory screening and central nociceptive activity was performed, further 
experiments were needed to elucidate their exact mechanism of activity. It can be 
concluded that these compounds certainly holds great promise towards good active 
leads in medicinal chemistry. 
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